EGFR and gastric cancer: Six of them (β-catenin, C-MYC, CXCL13, DC-SIGN, EGFR, and PIM2) are consistently described as oncogenes according to the literature, and are overexpressed at the protein or mRNA level in gastric tissue among infected children and gastric cancer patients.